MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Unveil the role of genetic testing in diagnosing CNS neoplasms. Learn about genetic markers, personalized treatment, prognosis, and familial risk assessment.
Nephroblastoma, also known as Wilms' tumor, is the most common type of kidney cancer in children.
Unlock key insights on neurodegeneration, its diagnosis, and how genetic testing identifies risks, aids early detection, and tailors personalized treatments effectively.
Genetic testing confirms Neurofibromatosis Type 2, identifies at-risk family members, and guides treatment. Learn about NF2's diagnosis, symptoms, and new therapies.
Genetic testing helps diagnose lactose intolerance, a condition where low lactase levels cause bloating and diarrhea. Early detection leads to personalized dietary advice.
How genetic testing identifies orthostatic hypotension. Learn about symptoms, diagnosis, personalized treatment plans, and preventive measures for OH.
Osteoarthritis (OA) is a pervasive musculoskeletal disorder that significantly impacts the quality of life of millions worldwide.
Ovarian serous cystadenocarcinoma is a type of epithelial ovarian cancer that originates in the cells lining the ovaries.